Open AccessThe burden of treatment and compliance with the epinephrine auto‐injector (EAI) in food allergic patients of all ages: a pilot study
Author(s) -
Kemna Jozephina C,
FlokstraDe Blok Bertine MJ,
Elberink Oude JNG,
Dubois Anthony EJ
Publication year - 2011
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-1-s1-o44
Subject(s) - medicine , food allergy , epinephrine , allergy , allergic reaction , anaphylaxis , pediatrics , intensive care medicine , immunology
Background Food allergic patients at risk for severe reactions should carry an epinephrine auto-injector (EAI). This treatment entails a burden for them and therefore may affect their compliance. Although the burden of treatment of an EAI has previously been shown to be high in vespid allergic patients, this has not yet been studied in food allergic patients. Therefore we determined the overall burden of treatment with the EAI in food allergic patients as perceived by both patients themselves and the parents of food allergic children. Furthermore, we examined the outcome of food allergic reactions requiring EAI use.